287 related articles for article (PubMed ID: 7511302)
1. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
Bonkhoff H; Remberger K
Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
[TBL] [Abstract][Full Text] [Related]
2. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
3. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
5. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
6. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
Landry F; Chapdelaine A; Bégin LR; Chevalier S
J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
[TBL] [Abstract][Full Text] [Related]
7. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
Tokar EJ; Ancrile BB; Cunha GR; Webber MM
Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690
[TBL] [Abstract][Full Text] [Related]
8. Unique features of the basal cells of human prostate epithelium.
El-Alfy M; Pelletier G; Hermo LS; Labrie F
Microsc Res Tech; 2000 Dec; 51(5):436-46. PubMed ID: 11074614
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives.
Xue Y; Smedts F; Verhofstad A; Debruyne F; de la Rosette J; Schalken J
Prostate Suppl; 1998; 8():62-73. PubMed ID: 9690665
[TBL] [Abstract][Full Text] [Related]
10. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
11. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
Bonkhoff H
Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
[TBL] [Abstract][Full Text] [Related]
13. Hormone regulation of human prostate in organ culture.
Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
Bonkhoff H; Stein U; Aumüller G; Remberger K
Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
[TBL] [Abstract][Full Text] [Related]
15. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
16. Clonal architecture of human prostatic epithelium in benign and malignant conditions.
Gaisa NT; Graham TA; McDonald SA; Poulsom R; Heidenreich A; Jakse G; Knuechel R; Wright NA
J Pathol; 2011 Oct; 225(2):172-80. PubMed ID: 21898875
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemistry of the prostate and prostate carcinomas].
Wernert N
Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
[TBL] [Abstract][Full Text] [Related]
19. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
20. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
